United States
Print page content Print
Increase text size Decrease text size
Text Size

BOVI-SHIELD GOLD ONE SHOT

Upgraded viral respiratory and Mannheimia (Pasteurella) haemolytica protection for your cattle.

BOVI-SHIELD GOLD ONE SHOT offers the longest demonstrated protection of the combination respiratory vaccines. It helps protect cattle for at least 279 days against infectious bovine rhinotracheitis (IBR) virus and bovine viral diarrhea (BVD) Types 1 and 2 viruses — at least 30% longer than Vista® Once SQ and longer demonstrated protection than Pyramid® 5 + Presponse® SQ, which has no duration of immunity claims.

In one convenient dose, BOVI-SHIELD GOLD ONE SHOT helps:

  • Provide superior protection against the major respiratory viruses and unmatched Mannheimia (Pasteurella) haemolytica protection
  • Prevent bovine respiratory disease (BRD), which can cost as much as $240 per head1,2
  • Protect your calves through the stress of weaning and transport to another operation
Expand All
  • Only BOVI-SHIELD GOLD ONE SHOT™ helps provide superior protection against the major respiratory viruses plus unmatched Mannheimia (Pasteurella) haemolytica protection in one convenient dose.

    The longest demonstrated respiratory protection against IBR and BVD Types 1 and 2

    • Demonstrated IBR and BVD Types 1 and 2 respiratory protection that lasts at least 30% longer than Vista® Once SQ
    • Has at least 279 days of immunity, longer demonstrated protection than Pyramid® 5 + Presponse® SQ, which has no duration of immunity claims
    • Longest demonstrated respiratory protection of the combination vaccines, helping protect through the stress of weaning, processing, shipping, commingling and arrival

    Upgraded protection for your cattle

    • Helps protects cattle from respiratory disease caused by infectious bovine rhinotracheitis (IBR) virus; bovine viral diarrhea (BVD) Types 1 and 2; bovine respiratory syncytial virus (BRSV); parainfluenza 3 (PI3) virus and M. haemolytica
    • Helps provide demonstrated protection that you’ve come to trust from BOVI-SHIELD GOLD® 5 and ONE SHOT® administered independently

    Helps boost your bottom line

    • Helps prevent bovine respiratory disease (BRD), which can result in losses of up to $240 per head1,2
    • First and only combination respiratory vaccine licensed to prevent IBR respiratory disease and BVD viremia, which helps minimize the spread of the virus through the blood stream
    • Only combination respiratory vaccine approved to aid in the prevention of M. haemolytica — the No. 1 calf killer 3,4

    The convenience of one dose

    • Convenient one-dose protection helps protect calves from BRD through weaning and on arrival, your busiest times of the year
  • Product Description: BOVI-SHIELD GOLD ONE SHOT is a freeze-dried preparation of modified-live virus (MLV) strains of IBR, BVD (Types 1 and 2), PI3 and BRSV viruses and product prepared from whole cultures of Mannheimia (Pasteurella) haemolytica propagated to increase the production of leukotoxin and capsular and cell-associated antigens. A sterile diluent, containing adjuvant to enhance the immune response, is provided to rehydrate the freeze-dried fraction.

    Label Claims: BOVI-SHIELD GOLD ONE SHOT is for vaccination of healthy cattle to prevent respiratory disease caused by infectious bovine rhinotracheitis (IBR) virus and viremia caused by bovine viral diarrhea (BVD) Types 1 and 2 viruses; and as an aid in preventing respiratory disease caused by BVD Types 1 and 2 viruses, parainfluenza 3 (PI3) virus, bovine respiratory syncytial virus (BRSV) and bovine pneumonia caused by M. haemolytica Type A1. A duration of immunity of at least nine months has been demonstrated against IBR and BVD Types 1 and 2 respiratory disease.

    Packaging: 5-, 10 and 50-dose vials

  • BOVI-SHIELD GOLD ONE SHOT may be administered to pregnant cattle provided they were vaccinated, according to label directions, with any BOVI-SHIELD GOLD FP® or PREGGUARD GOLD FP vaccine within the past 12 months. BOVI-SHIELD GOLD ONE SHOT also may be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months as described above. To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP product with the second dose administered approximately 30 days prebreeding.

    General Directions: Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze-dried component with the sterile diluent provided, shake well, and administer 2 mL subcutaneously. In accordance with Beef Quality Assurance guidelines, this product should be administered in the neck region.

    Primary Vaccination: Administer a single 2 mL dose to healthy cattle. To avoid possible maternal antibody interference with active immunization, calves vaccinated before the age of 6 months should be revaccinated after 6 months of age or at weaning.

    Revaccination: Annual revaccination with a single dose is recommended. Good management practices support revaccination whenever subsequent stress or exposure is likely.

  • PRECAUTIONS: Do not use in pregnant cows (abortions can result) unless they were vaccinated, according to label directions, with any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP vaccine within the past 12 months. Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months as described above. To help ensure safety in pregnant cattle, heifers must receive at least 2 doses of any BOVI-SHIELD GOLD FP or PREGGUARD GOLD FP product with the second dose administered approximately 30 days prebreeding.

    • Store at 2° to 7°C. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze.
    • Use entire contents when first opened.
    • Sterilized syringes and needles should be used to administer this vaccine.
    • Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine.
    • Burn containers and all unused contents.
    • Do not vaccinate within 21 days before slaughter.
    • Contains gentamicin as preservative.
    • As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
    • This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions or are otherwise immunocompromised, or if the vaccine is not administered in accordance with label directions.
  • 1

    Hicks B. Impact of Morbidity on Performance and Profitability of Feedlot Cattle. Beef Cattle Research Update. Oklahoma State University. Panhandle Research and Extension Center. May 2006:1-2.

    2

    Grubbs ST, Kania SA, Potgieter LND. Prevalence of ovine and bovine respiratory syncytial virus infection in cattle determined with a synthetic peptide-based immunoassay. J Vet Diagn Invest 2001;13(2):128-132.

    3

    Powell J. Livestock Health Series: Bovine Respiratory Disease. University of Arkansas, Cooperative Extension Service. FSA 3082. 2009. Available at: http://www.uaex.edu/Other_Areas/publications/PDF/FSA-3082.pdf. Accessed June 14, 2013.

    4

    U.S. Department of Agriculture. Mortality of Calves and Cattle on U.S. Beef Cow-calf Operations. Animal and Plant Health Plan Inspection Service. May 2010. Available at: http://www.aphis.usda.gov/animal_health/nahms/beefcowcalf/downloads/ beef0708/Beef0708_is_Mortality.pdf. Accessed June 14, 2013.

    BSO13004